Exagen Inc. Files 8-K
Ticker: XGN · Form: 8-K · Filed: May 9, 2025 · CIK: 1274737
| Field | Detail |
|---|---|
| Company | Exagen Inc. (XGN) |
| Form Type | 8-K |
| Filed Date | May 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
EXAGEN filed an 8-K, check for updates.
AI Summary
Exagen Inc. filed an 8-K on May 9, 2025, reporting an event that occurred on May 8, 2025. The filing is related to "Other Events" and "Financial Statements and Exhibits." No specific financial details or significant business events were detailed in the provided excerpt.
Why It Matters
This filing indicates Exagen Inc. is providing updates or disclosures to the SEC, which could contain material information for investors.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing notification without specific details of negative events or financial distress.
Key Players & Entities
- EXAGEN INC. (company) — Registrant
- May 8, 2025 (date) — Date of earliest event reported
- May 9, 2025 (date) — Filing Date
- 1261 Liberty Way Vista, CA 92081 (address) — Principal executive offices
FAQ
What specific event triggered this 8-K filing?
The filing indicates "Other Events" and "Financial Statements and Exhibits" as the items being reported, but the specific event is not detailed in the provided excerpt.
When was the earliest event reported in this filing?
The earliest event reported was on May 8, 2025.
What is Exagen Inc.'s principal executive office address?
Exagen Inc.'s principal executive offices are located at 1261 Liberty Way, Vista, CA 92081.
What is Exagen Inc.'s telephone number?
Exagen Inc.'s telephone number is (760) 560-1501.
What is Exagen Inc.'s former company name?
Exagen Inc.'s former company name was Exagen Diagnostics Inc., with a date of name change on December 30, 2003.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 9, 2025 regarding EXAGEN INC. (XGN).